Francesco M. Castelli
Expertise in
20
conditions

Francesco M. Castelli

Brescia, IT 
38 Years of Experience
Expertise in
20
conditions
Brescia, IT 

Overview

Francesco Castelli practices practicing medicine in Brescia, Italy. He has been practicing medicine for over 38 years.

Mr. Castelli is highly rated in 20 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis, Severe Acute Respiratory Syndrome (SARS), Bone Marrow Transplant, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 451 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Brescia, 25123, Italy
Other Locations
Verona, Italy
Pisa, 56126, Italy
Via Celoria 16, Milan, 20133, Italy
Catania, 95125, Italy
Via All'Opera Pia 15, Genoa, Italy
Florence, Italy
Pavia, 27100, Italy
Viale, 95125, Italy
Enna, 94100, Italy
Cosenza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drugs: Biktarvy, Symtuza
Study Phase: Phase 3
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
Enrollment Status: Terminated
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drugs: GSK3640254, ABC/3TC, FTC/TAF, Dolutegravir
Study Phase: Phase 2
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
View 2 Less Clinical Trials

450 Total Publications

Clinical and virological characteristics of hepatitis B virus genotype E infection: a case series.
Clinical and virological characteristics of hepatitis B virus genotype E infection: a case series.
Journal: Infectious diseases (London, England)
Published: August 03, 2026

Frequently Asked Questions about Francesco M. Castelli

Is Francesco M. Castelli a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Francesco M. Castelli is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Francesco M. Castelli participate in research or clinical trials?

Yes. Francesco M. Castelli has published 450 articles and abstracts on conditions like HIV/AIDS. You can view a list of Francesco M. Castelli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Castelli's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 70 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile